Back
Day Range
$10.01
$10.63
52-Week Range
$7.11
$11.17
Volume
1,561,412
50D / 200D Avg
$10.10
/
$9.54
Prev Close
$9.91
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -19.9 | 0.4 |
| P/B | 0.9 | 2.9 |
| ROE % | -4.6 | 3.7 |
| Net Margin % | -2.2 | 3.8 |
| Rev Growth 5Y % | 7.2 | 10.0 |
| D/E | 1.3 | 0.2 |
Key Takeaways
Revenue grew 7.23% annually over 5 years — modest growth
Earnings declined -178.29% over the past year
Generating 219.38M in free cash flow
PEG of 0.10 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 7.72%
ROIC of 4.08% — low return on invested capital
Growth
Revenue Growth (5Y)
7.23%
Revenue (1Y)-0.49%
Earnings (1Y)-178.29%
FCF Growth (3Y)23.77%
Quality
Return on Equity
-4.58%
ROIC4.08%
Net Margin-2.18%
Op. Margin5.74%
Safety
Debt / Equity
1.25
Current Ratio1.02
Interest Coverage1.76
Valuation
P/E Ratio
-19.91
P/B Ratio0.93
EV/EBITDA17.21
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0.49% | Revenue Growth (3Y) | 0.70% |
| Earnings Growth (1Y) | -178.29% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 7.23% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3.24B | Net Income (TTM) | -70.79M |
| ROE | -4.58% | ROA | -1.64% |
| Gross Margin | 17.52% | Operating Margin | 5.74% |
| Net Margin | -2.18% | Free Cash Flow (TTM) | 219.38M |
| ROIC | 4.08% | FCF Growth (3Y) | 23.77% |
| Safety | |||
| Debt / Equity | 1.25 | Current Ratio | 1.02 |
| Interest Coverage | 1.76 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -19.91 | P/B Ratio | 0.93 |
| P/S Ratio | 0.43 | PEG Ratio | 0.10 |
| EV/EBITDA | 17.21 | Dividend Yield | 0.00% |
| Market Cap | 1.41B | Enterprise Value | 3.21B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.24B | 3.26B | 3.20B | 2.97B | 2.45B |
| Net Income | -70.79M | 90.42M | -678.90M | 69.32M | 156.18M |
| EPS (Diluted) | -0.52 | 0.61 | -5.31 | 0.50 | 0.67 |
| Gross Profit | 568.56M | 681.09M | 681.77M | 417.43M | 445.61M |
| Operating Income | 186.27M | 263.73M | -598.40M | 190.41M | 225.61M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 4.32B | 4.49B | 4.51B | 5.22B | 5.25B |
| Total Liabilities | 2.79B | 2.91B | 3.04B | 3.06B | 3.18B |
| Shareholders' Equity | 1.52B | 1.57B | 1.46B | 2.15B | 2.06B |
| Total Debt | 1.90B | 2.13B | 2.29B | 2.33B | 2.37B |
| Cash & Equivalents | 106.14M | 109.75M | 77.13M | 46.27M | 149.63M |
| Current Assets | 728.90M | 755.79M | 649.02M | 585.31M | 670.06M |
| Current Liabilities | 712.39M | 566.99M | 537.00M | 456.21M | 499.81M |